Authors



Danielle A. Griggs, PharmD, MBA

Latest:

Clinical Studies for Closed-System Transfer Devices: Yes, They Matter

Closed-system transfer devices are an integral component in reducing occupational exposure to hazardous drugs.


Carolyn Dang, Long-shyang Chang, Katie Mai, Tammy Xie

Latest:

Roundup: Reviewing the Pharmacotherapy of AMI in the Health System

Mortality rates for acute myocardial infarction have decreased, but rapid response and chronic management are key to improving outcomes.


Feride Frech, PhD

Latest:

Cost Implications of Early Treatment Initiation Among Patients With Newly Diagnosed Fibromyalgia

Initiation of treatment with guideline-recommended medications within 60 days of fibromyalgia diagnosis was associated with immediate annual healthcare cost savings.


Duane Barnes, MS, MBA

Latest:

Synergies in Specialty: The 3 P's of Specialty Pharmacy--Pharmacy, Payer, and Product

In the development of a specialty pharmacy strategy, there are many key stakeholders, but none more important than the pharmacy, payer, and product. Each has its own mission and goals; however, at some point they must all come together.


Jeffrey Fudin, PharmD, FCCP, FASHP, FFSMB

Latest:

Offer Patients Counseling on ADFs

Pharmacists can extend education to prescribers and provide important guidance on abuse-deterrent opioid formulations.


Michell B. Butler, PharmD

Latest:

Improve Medication Adherence in Patients with HIV

Pharmacists can motivate patients to stick to their drug regimens to decrease viral load and prevent further transmission.



Katie McMillen, PharmD, MPh

Latest:

Securing Specialty Oncology Contracts in a Data-Driven World

Data aggregation partners can provide value in their ability to pull clinical information from both the HSSP and electronic health records.



Jeffery Talbert, PhD

Latest:

Healthcare Costs Associated With Chronic Opioid Use and Fibromayalgia Syndrome

While fibromyalgia is associated with a small increase in healthcare costs compared with matched controls, chronic opioid use in these patients results in a large increase.


Jeffrey D. Dunn, PharmD, MBA

Latest:

Leveraging Patient Care Services to Optimize Patient Care in RA: A Pharmacist’s Opportunity

This Continuing Education activity is supported by an educational grant from Sandoz Inc.


Douglas A. Nemecek, MD

Latest:

Clinical and Cost Outcomes of Buprenorphine Treatment in a Commercial Benefit Plan Population

Buprenorphine treatment with and without induction was found to decrease costs and utilization in opioid-dependent benefciaries.


Liza Patel, PharmD

Latest:

NAPLEX Preparation: Tips for the Most Important Exam of Your Career

Before you start preparing for NAPLEX, familiarize yourself with what to expect for the exam.


Jill Schachte, RPh, MSPBA

Latest:

Lifelong Learning in Specialty Pharmacy Goes Beyond Continuing Education Requirements

Recent pharmacy school graduates will find the benefits of investing in professional development to open new career paths.



Aislinn Antrim, Managing Editor

Latest:

Enhancing Patient Care in Heart Failure–Related Anemia Through Improved Communication, Monitoring, and Education

Pharmacists can optimize management of this condition with intravenous iron therapy guidance.


Amy Bao, PharmD Candidate

Latest:

Practicing Pharmacy Across the Pacific

As a first-year student pharmacist, I was initially overwhelmed by the number of student organizations and opportunities to get involved.


William Amarquaye, PharmD

Latest:

Importance of Sickle Cell Awareness Month Highlighted by Lack of Funding, Treatment Options

September has been designated as National Sickle Cell Awareness Month for the continued fostering of education surrounding sickle cell disease management.




Jill Murphy, Associate Editor

Latest:

Workplace Stress Was Highest Among Younger Employees During COVID-19 Pandemic

Study finds early career workers were more likely to disengage during the pandemic, such as by showing a lack of interest or becoming cynical about work.


Zhimei Liu, PhD

Latest:

Budget Impact of Everolimus in Treating Metastatic Renal Cell Carcinoma

A decision-analytical model shows that everolimus has a favorable budget impact when introduced into the treatment algorithm for metastatic renal cell carcinoma.


J. Jaime Caro, MDCM, FRCPC

Latest:

Persistence With Antiarrhythmics and the Impact on Atrial Fibrillation–Related Outcomes

Retrospective analysis of claims data showed that persistence with amiodarone and sotalol was generally poor.


Sarah M. Lorentz, PharmD

Latest:

Comparison of Pharmacists and Primary Care Providers as Immunizers

Pharmacist-administered vaccination services were found to be more efficient, productive, and cost-effective than primary care visits or mass vaccination clinics.


Suzanne Kelley, BPharm, CPh

Latest:

Palliative Care: The Role of the Pharmacist

Pharmacists are essential in developing an individualized treatment regimen for each patient.


Alain Koyama, ScD

Latest:

Does Medication Persistence in Diabetes Affect the Risk Of Hospitalization In The Short-Term?

An evaluation of the impact of persistence to oral antidiabetic medication on reducing the risk of hospitalization in adult patients with type 2 diabetes.


Michael M. Tran, PharmD, BCPS

Latest:

Telepharmacy and Its Impact on Formulary Adherence

Telepharmacy is comparable to usual care in transitioning members new to an HMO onto formulary medications.



C. Venkata S. Ram, MD

Latest:

Reduced Cardiovascular Risk and Healthcare Expenditures With Angiotensin Receptor Blocker/ Hydrochlorothiazide

Initial use of fixed-dose angiotensin receptor blocker/hydrochlorothiazide therapy may improve hypertension management, reduce risk of cardiovascular disease, and decrease long-term healthcare expenditures.